SEARCH

SEARCH BY CITATION

References

  • Broening, H.W., Bowyer, J.F. & Slikker, W. Jr. (1995). Age dependent sensitivity of rats to the long term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J. Pharmacol. Exp. Ther., 275, 325333.
  • Buchan, A. & Pulsinelli, W.A. (1990). Hypothermia but not the N-methyl-D-aspartate antagonist MK-801 attenuates neuronal damage in gerbils subjected to transient, severe global ischemia. J. Neurosci., 10, 311316.
  • Busto, R., Dietrich, W.D., Globus, M.Y., Valdos, A., Steinberg, P. & Ginsberg, W.D. (1987). Small differences in intraischemic brain temperature critically determine the extent of ischemic brain injury. J. Cereb. Blood Flow Metab., 7, 729738.
  • Cadet, J.L., Ladenheim, B., Baum, I., Carlson, E. & Epstein, C. (1994). CuZn-superoxide dismutase (CuZn-SOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). Brain Res., 655, 259262.
  • Colado, M.I. & Green, A.R. (1995). The spin trap reagent α-phenyl-N-tert-butyl nitrone prevents neurodegeneration following administration of ‘ecstasy’. Eur. J. Pharmacol., 280, 343346.
  • Colado, M.I., Murray, T.K. & Green, A.R. (1993). 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br. J. Pharmacol., 108, 583589.
  • Colado, M.I., O'Shea, E., Granados, R., Esteban, B. & Green, A.R. (1997a). The role of temperature in the neuroprotective effect of clomethiazole against MDMA-induced degeneration in rat brain. Br. J. Pharmacol., 122, 304P.
  • Colado, M.I., O'Shea, E., Granados, R., Misra, A., Murray, T.K. & Green, A.R. (1997b). A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br. J. Pharmacol., 121, 827833.
  • Colado, M.I., O'Shea, E., Granados, R., Murray, T.K. & Green, A.R. (1997c). In vivo evidence for free radical involvement in the degereration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine. Br. J. Pharmacol., 121, 889900.
  • Colado, M.I., Williams, J.L. & Green, A.R. (1995). The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metaboliser phenotype. Br. J. Pharmacol., 115, 12811289.
  • Corbett, D., Evans, S., Thomas, L., Wang, D. & Jonas, R. (1990). MK 801 reduces cerebral ischaemic injury by inducing hypothermia. Brain Res., 514, 300304.
  • Cregan, E.F., Peeling, J., Corbett, D., Buchan, A.M., Saunders, J., Auer, R.N., Gao, M., Mccarthy, D.J., Eisman, M.S., Campbell, T.M., Stagnitto, M.L. & Palmer, G.C. (1997). ARL 15896AR, a low affinity uncompetitive NMDA antagonist, is effective in rodent models of global and focal ischemia. J. Pharmacol. Exp. Ther., 283, 14121424.
  • Cross, A.J., Snape, M.F. & Green, A.R. (1993). Chlormethiazole antagonises seizures induced by N-methyl-D-aspartate without interacting with the NMDA receptor complex. Psychopharmacology, 112, 403406.
  • Cross, A.J., Stirling, J.M., Robinson, T.N., Bowen, D.M., Francis, P.T. & Green, A.R. (1989). The modulation by chlormethiazole of GABAA-receptor complex in rat brain. Br. J. Pharmacol., 104, 284289.
  • Dafters, R.I. (1994). Effects of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymetham-phetamine (MDMA or ‘ecstasy’) in rats. Psychopharmacology, 114, 505508.
  • Farfel, C.M. & Seiden, L.S. (1995a). Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments with 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J. Pharmacol. Exp. Ther., 272, 860867.
  • Farfel, G.M. & Seiden, L.S. (1995b). Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Effects with methamphetamine, p-chloramphetamine, fenfluramine, dizocilpine and dextromethorphan. J. Pharmacol. Exp. Ther., 272, 868875.
  • Farfel, G.M., Vosmer, G.L. & Seiden, L.S. (1992). The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxy-methamphetamine and p-chloroamphetamine. Brain Res., 595, 121127.
  • Finnegan, K.T., Skratt, J.J., Irwin, I. & Langston, J.W. (1990). The N-methyl-D-aspartate antagonist dextrorphan prevents the neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in rats. Neurosci. Letts., 105, 300306.
  • Globus, M.Y.-T., Busto, R., Lin, B., Schnippering, H. & Ginsberg, M.D. (1995). Detection of free radical formation during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J. Neurochem., 65, 12501256.
  • Gordon, C.J., Watkinson, W.P., O'Callaghan, J.P. & Miller, D.B. (1991). Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses in the rat. Pharmacol. Biochem. Behav., 38, 339344.
  • Green, A.R. (1998). Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy. Pharmacol. Ther., (in press).
  • Green, A.R. & Cross, A.J. (1994). The neuroprotective actions of chlormethiazole. Prog. Neurobiol., 44, 463484.
  • Green, A.R., Cross, A.J. & Goodwin, G.M. (1995). Review of the pharmacology and clinical pharmacology of 3,4-methylenediox-ymethamphetamine (MDMA or ‘Ecstasy’). Psychopharmacology, 119, 247260.
  • Green, A.R., Misra, A. & Cross, A.J. (1997). In vitro studies on the interaction of clomethiazole with glutamate receptor sub-types in rat brain. Br. J. Pharmacol., 122, 328P.
  • Green, A.R., Misra, A., Murray, T.K., Snape, M.F. & Cross, A.J. (1996). A behavioural and biochemical study in rats of the pharmacology of loreclezole, a novel allosteric modulator of the GABAA receptor. Neuropharmacology, 35, 12431250.
  • Greene, J.G., Porter, R.H. & Greenamyre, J.T. (1996). ARL-15896, a novel N-methyl-D-aspartate receptor ion channel antagonist. Neuroprotection against mitochondrial metabolic toxicity and regional pharmacology. Exp. Neurol., 137, 6672.
  • Hewitt, K.E. & Green, A.R. (1994). Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy'). Neuropharmacology, 33, 15891595.
  • Kil, H.Y., Zhang, J. & Plantadosi, L.A. (1996). Brain temperature alters hydroxyl radical production during cerebral ischaemia/l reperfusion in rats. J. Cereb. Blood Flow Metab., 16, 100106.
  • Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265275.
  • Malberg, J.E., Sabol, K.E. & Seiden, L.S. (1996). Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J. Pharmacol. Exp. Ther., 278, 258267.
  • Murray, T.K., Williams, J.L., Misra, A., Colado, M.I. & Green, A.R. (1996). The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine. Neuropharmacology, 35, 16151620.
  • Nash, J.F., Meltzer, H.Y. & Gudelsky, G.A. (1988). Elevation of serum prolactin and corticosterone concentrations after administration of 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther., 245, 873879.
  • Nurse, S. & Corbett, D. (1996). Neuroprotection after several days of mild drug-induced hypothermia. J. Cereb. Blood Flow Metab., 16, 474480.
  • Palmer, G.C., Miller, J.A., Cregan, E.F., Gendron, P. & Peeling, J. (1997). Low affinity NMDA antagonists: the neuroprotective potential of ARL 15896AR. Ann. New York Acad. Sci., 825, 220231.
  • Small, D.L. & Buchan, A.M. (1997). NMDA antagonists: their role in neuroprotection In Neuroprotective Agents and Cerebral Ischaemia ed. Green, A.R. & Cross, A.J. pp. 137171.London: Academic Press.
  • Sprague, J.E. & Nichols, D.E. (1995). The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxy-methamphetamine-induced lipid peroxidation and long-term serotonergic deficits. J. Pharmacol. Exp. Ther., 273, 667673.
  • Steele, T.D., Mccann, U.D. & Ricaurte, G.A. (1994). 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’); pharmacology and toxicology in animals and humans. Addiction, 89, 539551.